Investigating how radiation therapy combined with specific drugs can enhance immune responses against tumors.
Systemic/Abscopal Anti-Tumor Immune Responses during IAP Antagonism and Radiation
This study is looking at how radiation therapy can help your immune system fight not just the cancer in your head and neck, but also tumors in other areas of your body, and it’s testing a combination of treatments to see if they can make this immune response even stronger.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11120595 on NIH RePORTER |
What this research studies
This research focuses on the effects of radiation therapy on locally advanced head and neck cancer, particularly how it can stimulate the immune system to attack tumors outside the treated area, known as the abscopal effect. The study explores the combination of radiation with IAP antagonists and anti-PD-1 therapies to enhance the immune response against cancer. By analyzing patient samples, the research aims to understand how these treatments can improve tumor control and activate T-cells, which are crucial for fighting cancer. Patients may be involved in trials to assess the effectiveness of these combined therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with locally advanced head and neck cancer who are undergoing radiation therapy.
Not a fit: Patients with early-stage head and neck cancer or those who are not receiving radiation therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for head and neck cancer, potentially improving survival rates and quality of life for patients.
How similar studies have performed: Previous research has shown promising results with similar approaches, indicating potential for significant advancements in cancer treatment.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Schmitt, Nicole Cherie — Emory University
- Study coordinator: Schmitt, Nicole Cherie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.